5 results
management diagnosis hematology blood reactions activation algorithm antinxp2 antinxp2dm dermatomyositis guidelines macrophage mas nodosa pan polyarteritis syndrome transfusion transfusions vasculitis
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines • Severe Disease → Remission
• Non-Severe Disease ... immunosuppressive agent (e.g ... Vasculitis #Management #Treatment ... #ACR2021 #Guidelines ... #algorithm #rheumatology
Blood Product Transfusions One Pager Summary Type and screen - determines blood type and detects in recipient
in recipient (e.g ... Graft Versus Host Disease ... RBCs (stored at 4C ... Borrellia (Lyme disease ... diagnosis #management #hematology
Blood Transfusion Reactions Immune Mediated: • Febrile Non-Hemolytic Transfusion Reaction (FNHTR): Most common immune reaction to transfusion.
FNHTR once had ... Blood products contain ... Infection - Infection ... RBCs (stored at 4C ... diagnosis #management #hematology
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
SLE], AOSD) • Infection ... Fibrin degradation products ... Treatment: • Corticosteroids ... Diagnosis #Management #Hematology ... #Rheumatology
Anti-NXP-2 Dermatomyositis What? DM with generalized subcutaneous edema Pts have more myalgias, more severe weakness, and an increased prevalence
chest (in a V-sign ... more severe disease ... positive patients Treatment ... diagnosis #management #rheumatology ... #dermatology
No results found for "PAD cardiology sign injection ekg treatment rheumatology a4c disease product acr2021 dermatology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PAD #cardiology #sign #injection #ekg #treatment #rheumatology #a4c #disease #product #acr2021 #dermatology